{"id":"NCT03092375","sponsor":"University of Florida","briefTitle":"Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects","officialTitle":"A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects With Chronic Hepatitis C Previously Treated With an NS5A Inhibitor + Sofosbuvir Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-04-20","primaryCompletion":"2018-12-28","completion":"2020-02-06","firstPosted":"2017-03-27","resultsPosted":"2020-02-05","lastUpdate":"2020-02-26"},"enrollment":177,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C","HCV"],"interventions":[{"type":"DRUG","name":"Glecaprevir/Pibrentasvir (G/P) 300mg/120mg","otherNames":["Glecaprevir/Pibrentasvir","GLE/PIB (Glecaprevir/Pibrentasvir)"]},{"type":"DRUG","name":"Ribavirin 200Mg Tablet","otherNames":["Ribasphere 200Mg Tablet"]}],"arms":[{"label":"Arm A: G/P 300 mg/120 mg QD for 12 Wks","type":"EXPERIMENTAL"},{"label":"Arm B: G/P 300 mg/120 mg QD for 16 Wks","type":"EXPERIMENTAL"},{"label":"Arm C: G/P 300 mg/120 mg QD + RBV 12 Wks","type":"EXPERIMENTAL"},{"label":"Arm D: G/P 300 mg/120 mg QD for 16 Wks","type":"EXPERIMENTAL"}],"summary":"The study will enroll well-compensated cirrhotic as well as non-cirrhotic subjects treatment experienced with an NS5a Inhibitor + sofosbuvir and will include patients who did not complete the prescribed duration due to adverse event or any reason other than for non/poor compliance. Subjects will be randomized to 12 or 16 weeks of treatment.","primaryOutcome":{"measure":"SVR After G/P 12 Wks (Arm A) vs. G/P Given for 16 Weeks (Arm B) to Non-cirrhotic Treatment-experienced GT1 HCV Participants","timeFrame":"Up to 28 weeks","effectByArm":[{"arm":"Arm A: G/P 300 mg/120 mg QD for 12 Wks","deltaMin":70,"sd":null},{"arm":"Arm B: G/P 300 mg/120 mg QD for 16 Wks","deltaMin":46,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":31,"countries":["United States"]},"refs":{"pmids":["34023351","31401140"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":78},"commonTop":["Fatigue","Headache","Nausea","Arthralgia","Arthralgia"]}}